Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Medical Properties Trust Trading Up 1.9 %
Medical Properties Trust stock opened at $16.18 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.64 and a debt-to-equity ratio of 1.14. Medical Properties Trust has a 12 month low of $14.10 and a 12 month high of $24.13. The stock's 50 day simple moving average is $16.03 and its two-hundred day simple moving average is $18.68. The firm has a market cap of $9.71 billion, a PE ratio of 8.09, a P/E/G ratio of 0.88 and a beta of 0.75.
Medical Properties Trust Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, July 14th. Stockholders of record on Thursday, June 16th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 7.17%. The ex-dividend date was Wednesday, June 15th. Medical Properties Trust's payout ratio is 58.00%.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. lowered Medical Properties Trust from an "overweight" rating to a "neutral" rating and dropped their target price for the company from $24.00 to $18.00 in a research report on Wednesday, June 22nd. Truist Financial dropped their target price on Medical Properties Trust from $23.00 to $18.00 in a research report on Monday, July 11th. Barclays dropped their target price on Medical Properties Trust from $27.00 to $23.00 and set an "overweight" rating on the stock in a research report on Thursday, August 4th. Credit Suisse Group lowered Medical Properties Trust from an "outperform" rating to a "neutral" rating and dropped their target price for the company from $23.00 to $17.00 in a research report on Thursday, July 14th. Finally, KeyCorp dropped their target price on Medical Properties Trust from $23.00 to $18.00 and set an "overweight" rating on the stock in a research report on Thursday, July 7th. Seven equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.64.